Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose Rituximab and High-dose Dexamethasone in ITP
NCT01107951Phase 2Completed
- Sponsor
- Hospital Universitario Dr. Jose E. Gonzalez
- Start
- Apr 2010
- Primary completion
- Apr 2010
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of rituximab in immune thrombocytopenic purpura (ITP), sponsored by Hospital Universitario Dr. Jose E. Gonzalez. Primary endpoint: Number of patients with sustained response after 6 months. Started Apr 2010; status: completed.
02
Drugs
rituximab
03
Conditions
immune thrombocytopenic purpura (ITP)
Beyond the preview
Go deeper on NCT01107951.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01107951.